Amyotrophic lateral sclerosis: moving towards a new classification system (Q38959347)

8 September 2017

1 reference

title

Amyotrophic lateral sclerosis: moving towards a new classification system (English)

1 reference

amyotrophic lateral sclerosis

8 September 2017

main subject

0 references

author

Orla Hardiman

series ordinal

2

1 reference

8 September 2017

1

Ammar Al-Chalabi

1 reference

8 September 2017

Leonard H van den Berg

series ordinal

6

object named as

Leonard H van den Berg

1 reference

8 September 2017

3

Matthew C Kiernan

1 reference

8 September 2017

4

Adriano Chiò

1 reference

8 September 2017

Benjamin Rix-Brooks

5

1 reference

8 September 2017

publication date

1 October 2016

1 reference

8 September 2017

1 reference

8 September 2017

volume

15

1 reference

8 September 2017

issue

11

1 reference

8 September 2017

page(s)

1182-1194

1 reference

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Prognosis of amyotrophic lateral sclerosis with respiratory onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Natural history and clinical features of the flail arm and flail leg ALS variants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Natural history of young-adult amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Controversies and priorities in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The genetics and neuropathology of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Electrodiagnostic criteria for diagnosis of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

ALS drug development: reflections from the past and a way forward

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Biomarkers in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Experience with the Awaji Island modifications to the ALS diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Are we really closer to improving the diagnostic sensitivity in ALS patients with Awaji criteria?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Lower motor neuron involvement examined by quantitative electromyography in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

AWAJI criteria are not always superior to the previous criteria: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A diagnostic system using broad categories with clinically relevant specifiers: lessons for ICD-11.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Quality Control of Motor Unit Number Index (MUNIX) Measurements in 6 Muscles in a Single-Subject "Round-Robin" Setup

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Disease course and prognostic factors of progressive muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Sporadic lower motor neuron disease with adult onset: classification of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A revision of the El Escorial criteria - 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The natural history of primary lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A case of presumptive primary lateral sclerosis with upper and lower motor neurone pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Cortical excitability distinguishes ALS from mimic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Isolated bulbar phenotype of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Survival profiles of patients with frontotemporal dementia and motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Are amyotrophic lateral sclerosis patients cognitively normal?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Amyotrophic lateral sclerosis in an urban setting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Young-onset amyotrophic lateral sclerosis: historical and other observations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A clinical tool for predicting survival in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Progression in ALS is not linear but is curvilinear.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

An exploratory spatial analysis of ALS incidence in Ireland over 17.5 years (1995-July 2013).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Latent cluster analysis of ALS phenotypes identifies prognostically differing groups

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

ALS-Plus - where does it begin, where does it end?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Central white matter degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

18F-FDG-PET correlates of cognitive impairment in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Absence of consensus in diagnostic criteria for familial neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Proposed criteria for familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Modelling the effects of penetrance and family size on rates of sporadic and familial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

An estimate of amyotrophic lateral sclerosis heritability using twin data.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

ALSOD: The Amyotrophic Lateral Sclerosis Online Database

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Using reference databases of genetic variation to evaluate the potential pathogenicity of candidate disease variants.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The risk to relatives of patients with sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Association of lead exposure with survival in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Evidence of an environmental effect on survival in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Modification of the association between lead exposure and amyotrophic lateral sclerosis by iron and oxidative stress related gene polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Diagnostic yield and cost-effectiveness of investigations in patients presenting with isolated lower motor neuron signs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The clinical spectrum of isolated peripheral motor dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Clinical significance of cation channel antibodies in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

A proposed staging system for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The El Escorial criteria: Strengths and weaknesses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Brain MR Imaging in Patients with Lower Motor Neuron-Predominant Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Stages of pTDP-43 pathology in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The classification of neurological disorders in the 11th revision of the International Classification of Diseases (ICD-11).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The need to revise pain diagnoses in ICD-11

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

ICD coding for epilepsy: past, present, and future--a report by the International League Against Epilepsy Task Force on ICD codes in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Functional disorders in the Neurology section of ICD-11: A landmark opportunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Primary Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Progressive Muscular Atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The development of the ICD-11 Clinical Descriptions and Diagnostic Guidelines for Mental and Behavioural Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

The classification of Obsessive-Compulsive and Related Disorders in the ICD-11.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930199-5

7 January 2021

10.1016/S1474-4422(16)30199-5

Identifiers

DOI

1 reference

8 September 2017

1 reference